Quinidine partially blocks mitochondrial voltage-dependent anion channel (VDAC)

European Biophysics Journal : EBJ
Chetan Malik, Subhendu Ghosh

Abstract

Quinidine is an antiarrhythmic drug commonly used for the treatment of cardiac ailments. It affects oxidative phosphorylation, calcium uptake, and ion channels of mitochondria. We have investigated the interaction of Quinidine and mitochondrial voltage-dependent anion channel (VDAC). VDAC was purified from neuronal tissue of Wistar rats and in vitro bilayer electrophysiology experiments were performed on it. 50-mM Quinidine treatment on VDAC leads to a sudden drop in its conductance. The dose of Quinidine leading to a half-maximal current through a single-channel VDAC was calculated using Quinidine at different concentrations. In silico molecular docking studies using Autodock-4.2 software indicate interaction between Quinidine and VDAC. Docking results demonstrate the interaction of Quinidine and VDAC on its Glutamic acid residue (Glu-206 of VDAC). Fluorescence spectroscopy results on Quinidine and Glutamic acid interaction show an increase in the intensity and wavelength of Quinidine fluorescence, whereas no interaction between Quinidine and Cysteine was observed. This further supports the Glutamic acid and Quinidine interaction. In conclusion, we report Quinidine partially blocks VDAC due to the interaction of Glutamic acid ...Continue Reading

References

May 1, 1979·Biochemical Pharmacology·H Komai, H A Berkoff
Feb 1, 1992·Journal of Bioenergetics and Biomembranes·F P Thinnes
May 1, 1992·British Journal of Clinical Pharmacology·J C BloomerG T Tucker
Oct 1, 1989·The Journal of Membrane Biology·M Colombini
Mar 28, 1986·Biochemical and Biophysical Research Communications·J J Diwan
Apr 6, 1995·Biochemical and Biophysical Research Communications·A K BeraS Das
Jun 9, 1995·The Journal of Biological Chemistry·W H YuM Forte
Jul 1, 1994·Journal of Cardiovascular Electrophysiology·S Lévy, S Azoulay
Aug 1, 1993·Circulation Research·A YataniA Bahinski
Jun 1, 1997·The Journal of Membrane Biology·T Hodge, M Colombini
Mar 25, 1998·Mayo Clinic Proceedings·M J Ackerman
Aug 13, 1999·Genes & Development·A GrossS J Korsmeyer
Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·T K RostovtsevaS M Bezrukov
Feb 13, 2001·Journal of Neurophysiology·C B Ransom, H Sontheimer
Sep 8, 2004·Biochemical and Biophysical Research Communications·Jyotirmoy Banerjee, Subhendu Ghosh
Sep 24, 2004·The Journal of Membrane Biology·P BednarczykA Szewczyk
Aug 26, 2006·Cell Calcium·Adrian IsraelsonVarda Shoshan-Barmatz
Jun 26, 2007·Cell Calcium·Adrian IsraelsonVarda Shoshan-Barmatz
Aug 1, 2008·Journal of Bioenergetics and Biomembranes·Vito De PintoAngela Messina
Aug 7, 2008·Journal of Bioenergetics and Biomembranes·John G Pastorino, Jan B Hoek
Oct 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Monika BayrhuberKornelius Zeth
Nov 8, 2008·Proceedings of the National Academy of Sciences of the United States of America·Rachna UjwalJeff Abramson
Apr 29, 2009·Journal of Computational Chemistry·Garrett M MorrisArthur J Olson
Aug 4, 2009·Trends in Biochemical Sciences·Marco Colombini
Feb 27, 2010·FEBS Letters·Vito De PintoAlfons Lawen
Oct 13, 2010·Molecular and Cellular Biology·Nurit KeinanVarda Shoshan-Barmatz
Feb 2, 2011·Biophysical Journal·Huan RuiWonpil Im
Jul 19, 2011·Developmental Cell·Jean-Claude Martinou, Richard J Youle
Oct 25, 2011·Biochimica Et Biophysica Acta·Angela MessinaVito De Pinto
Nov 9, 2011·Biochimica Et Biophysica Acta·Kyle S McCommis, Christopher P Baines
Jan 14, 2012·Biochimica Et Biophysica Acta·Marco Colombini
Oct 31, 2012·PloS One·Barbara MertinsLars-Oliver Essen
Aug 30, 2013·Expert Opinion on Therapeutic Targets·George S KrasnovAnna V Kudryavtseva
Dec 3, 2014·Biochimica Et Biophysica Acta·Varda Shoshan-BarmatzShambhoo Sharan Tripathi
Feb 28, 2015·Biochemical and Biophysical Research Communications·Rajeev Gupta, Subhendu Ghosh
Jan 21, 2017·Oncology Letters·Xiao-Ying Zhang, Pei-Ying Zhang

❮ Previous
Next ❯

Methods Mentioned

BETA
Fluorescence
fluorescence spectroscopy

Software Mentioned

Autodock
RasMOL
Ligplot
Origin
Ligplot +
PyMOL Molecular Graphics System
PyMOL
pCLAMP

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Related Papers

Soins; la revue de référence infirmière
L Portet-Brunet
Annales de cardiologie et d'angéiologie
J Di Matteo, J C Delvaux
Journal of the American Medical Association
L N KATZ
France Medecine
C PIOT
Annals of the New York Academy of Sciences
J W Mason, L M Hondeghem
© 2021 Meta ULC. All rights reserved